Yan-qiu Zhao
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
BCL-2/BCL-xL inhibitor pelcitoclax with osimertinib for EGFR-mutated advanced non-small-cell lung cancer: a phase 1b trial.
Journal: Journal for immunotherapy of cancer
Published: June 03, 2026
AKR1C1 expression is induced by hexavalent chromium exposure and lung squamous carcinoma development for mediating lipid metabolic dysregulation.
Journal: Talanta
Published: January 24, 2026
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 02, 2025
METTL3 in Cr (VI)-induced carcinogenesis and CXCL6 expression associated with lung cancer development.
Journal: Genes & diseases
Published: January 30, 2025
The first-in-class bispecific antibody IBI318 (LY3434172) targeting PD-1 and PD-L1 in patients with advanced tumors: a phase Ia/Ib study.
Journal: Journal of hematology & oncology
Published: October 17, 2024
Hexavalent chromium induced metabolic reprogramming, carcinogenesis and tumor progression through PDK1 upregulation.
Journal: Ecotoxicology and environmental safety
Published: July 16, 2024
Elevated NOX4 promotes tumorigenesis and acquired EGFR-TKIs resistance via enhancing IL-8/PD-L1 signaling in NSCLC.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: October 04, 2022
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study.
Journal: Cancer immunology, immunotherapy : CII
Published: July 19, 2021
HB-EGF Activates the EGFR/HIF-1α Pathway to Induce Proliferation of Arsenic-Transformed Cells and Tumor Growth.
Journal: Frontiers in oncology
Published: January 18, 2020
Correlation between pre-treatment serum carcinoembryonic antigen levels and genotypes in a large population of Chinese people with advanced lung adenocarcinoma.
Journal: Internal medicine journal
Published: May 19, 2018
Geraniin suppresses ovarian cancer growth through inhibition of NF-κB activation and downregulation of Mcl-1 expression.
Journal: Journal of biochemical and molecular toxicology
Published: December 08, 2016
[Retracted] Bergamottin isolated from Citrus bergamia exerts in vitro and in vivo antitumor activity in lung adenocarcinoma through the induction of apoptosis, cell cycle arrest, mitochondrial membrane potential loss and inhibition of cell migration and invasion.
Journal: Oncology reports
Published: December 03, 2015
Last Updated: 09/26/2026